Indeed, genetic mutations in components of this pathway such as APC, AXIN1/2 and CTNNB1 are well-established molecular events in colorectal, as well as gastric carcinomas and HCC [39], [40]. This evidence concerns the gene AXIN1 and gastric carcinoma.